Effect of Aggregate Microtexture Losses on Skid Resistance: Laboratory-Based Assessment on Chip Seals

2020 ◽  
Vol 32 (4) ◽  
pp. 04020040
Author(s):  
Basri Ergin ◽  
İslam Gökalp ◽  
Volkan Emre Uz
Keyword(s):  
Author(s):  
Shuo Li ◽  
Todd Shields ◽  
Samy Noureldin ◽  
Yi Jiang

Chip seal has been widely used as an effective surface treatment for pavement preservation. The Indiana Department of Transportation (DOT) chip sealed a total of 373 lane mile pavements in 2008 and 700 lane mile pavements in 2009. However, many issues, such as the optimal use of local materials and new aggregates, remained unsolved. No original information was available at the time for Indiana DOT engineers to assess the performance of chip seal pavements. A research study was initiated by the Indiana DOT to evaluate the field performance of chip seal pavements, particularly the surface friction properties. Eighteen chip seal projects were selected as the test sections for this study. Field testing was conducted to measure pavement surface friction and texture properties. The true surface friction numbers were identified for chip seals after 12 months of service. The variation of surface friction on chip seals was analyzed. Factors affecting chip seal surface friction, such as aggregate, traffic volume, and existing pavement condition, were identified and examined. Three traffic levels were defined for better chip seal application. The international roughness index on the existing pavement affected chip seal friction performance. A criterion was recommended for assessing the friction performance of chip seal and identifying the possible failure of a chip seal.


2020 ◽  
Vol 477 (14) ◽  
pp. 2679-2696
Author(s):  
Riddhi Trivedi ◽  
Kalyani Barve

The intestinal microbial flora has risen to be one of the important etiological factors in the development of diseases like colorectal cancer, obesity, diabetes, inflammatory bowel disease, anxiety and Parkinson's. The emergence of the association between bacterial flora and lungs led to the discovery of the gut–lung axis. Dysbiosis of several species of colonic bacteria such as Firmicutes and Bacteroidetes and transfer of these bacteria from gut to lungs via lymphatic and systemic circulation are associated with several respiratory diseases such as lung cancer, asthma, tuberculosis, cystic fibrosis, etc. Current therapies for dysbiosis include use of probiotics, prebiotics and synbiotics to restore the balance between various species of beneficial bacteria. Various approaches like nanotechnology and microencapsulation have been explored to increase the permeability and viability of probiotics in the body. The need of the day is comprehensive study of mechanisms behind dysbiosis, translocation of microbiota from gut to lung through various channels and new technology for evaluating treatment to correct this dysbiosis which in turn can be used to manage various respiratory diseases. Microfluidics and organ on chip model are emerging technologies that can satisfy these needs. This review gives an overview of colonic commensals in lung pathology and novel systems that help in alleviating symptoms of lung diseases. We have also hypothesized new models to help in understanding bacterial pathways involved in the gut–lung axis as well as act as a futuristic approach in finding treatment of respiratory diseases caused by dysbiosis.


2016 ◽  
Vol 136 (6) ◽  
pp. 244-249
Author(s):  
Takahiro Watanabe ◽  
Fumihiro Sassa ◽  
Yoshitaka Yoshizumi ◽  
Hiroaki Suzuki

Sign in / Sign up

Export Citation Format

Share Document